Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P33
Within normal range
vs 2Y Ago
-3.6x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-144.16M+50.5%
2024$-290.98M-829.4%
2023$39.89M+119.9%
2022$-200.85M-143.1%
2021$-82.64M-111.9%
2020$-39.00M-3601.3%
2019$1.11M-